PortfoliosLab logo
COO vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between COO and BSX is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

COO vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Cooper Companies, Inc. (COO) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

COO:

-0.76

BSX:

1.82

Sortino Ratio

COO:

-1.00

BSX:

2.27

Omega Ratio

COO:

0.86

BSX:

1.36

Calmar Ratio

COO:

-0.64

BSX:

2.58

Martin Ratio

COO:

-1.58

BSX:

10.49

Ulcer Index

COO:

16.16%

BSX:

3.82%

Daily Std Dev

COO:

32.23%

BSX:

22.33%

Max Drawdown

COO:

-98.75%

BSX:

-89.15%

Current Drawdown

COO:

-40.07%

BSX:

-1.31%

Fundamentals

Market Cap

COO:

$13.65B

BSX:

$155.73B

EPS

COO:

$2.07

BSX:

$1.37

PE Ratio

COO:

32.99

BSX:

76.83

PEG Ratio

COO:

1.17

BSX:

2.59

PS Ratio

COO:

3.42

BSX:

8.87

PB Ratio

COO:

1.65

BSX:

7.01

Total Revenue (TTM)

COO:

$2.99B

BSX:

$17.55B

Gross Profit (TTM)

COO:

$1.95B

BSX:

$11.79B

EBITDA (TTM)

COO:

$661.60M

BSX:

$4.09B

Returns By Period

In the year-to-date period, COO achieves a -25.73% return, which is significantly lower than BSX's 17.85% return. Over the past 10 years, COO has underperformed BSX with an annualized return of 4.15%, while BSX has yielded a comparatively higher 19.13% annualized return.


COO

YTD

-25.73%

1M

-17.04%

6M

-34.64%

1Y

-27.60%

3Y*

-7.99%

5Y*

-2.92%

10Y*

4.15%

BSX

YTD

17.85%

1M

0.31%

6M

16.10%

1Y

39.29%

3Y*

36.92%

5Y*

22.61%

10Y*

19.13%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


The Cooper Companies, Inc.

Boston Scientific Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

COO vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COO
The Risk-Adjusted Performance Rank of COO is 1010
Overall Rank
The Sharpe Ratio Rank of COO is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of COO is 1212
Sortino Ratio Rank
The Omega Ratio Rank of COO is 1111
Omega Ratio Rank
The Calmar Ratio Rank of COO is 1111
Calmar Ratio Rank
The Martin Ratio Rank of COO is 44
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9393
Overall Rank
The Sharpe Ratio Rank of BSX is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9191
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9595
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

COO vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Cooper Companies, Inc. (COO) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current COO Sharpe Ratio is -0.76, which is lower than the BSX Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of COO and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

COO vs. BSX - Dividend Comparison

Neither COO nor BSX has paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
COO
The Cooper Companies, Inc.
0.00%0.00%0.02%0.02%0.01%0.02%0.02%0.02%0.03%0.03%0.04%0.04%
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

COO vs. BSX - Drawdown Comparison

The maximum COO drawdown since its inception was -98.75%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for COO and BSX.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

COO vs. BSX - Volatility Comparison

The Cooper Companies, Inc. (COO) has a higher volatility of 17.24% compared to Boston Scientific Corporation (BSX) at 4.53%. This indicates that COO's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

COO vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between The Cooper Companies, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
964.70M
4.66B
(COO) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

COO vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between The Cooper Companies, Inc. and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%62.0%64.0%66.0%68.0%70.0%JulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
68.4%
68.8%
(COO) Gross Margin
(BSX) Gross Margin
COO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported a gross profit of 660.20M and revenue of 964.70M. Therefore, the gross margin over that period was 68.4%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

COO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported an operating income of 182.00M and revenue of 964.70M, resulting in an operating margin of 18.9%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

COO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, The Cooper Companies, Inc. reported a net income of 104.30M and revenue of 964.70M, resulting in a net margin of 10.8%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.